Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 608432, 8 pages
http://dx.doi.org/10.1155/2015/608432
Research Article

Multifunctional Silica Nanoparticles Modified via Silylated-Decaborate Precursors

1Institut Charles Gerhardt, UMR 5253, CC 1701, Equipe Chimie Moléculaire et Organisation du Solide, Université de Montpellier, Place Eugéne Bataillon, 34090 Montpellier Cedex 05, France
2Laboratoire de Chimie de Coordination Inorganique et Organométallique LCIO, Université Libanaise, Faculté des Sciences I, Hadath, Lebanon
3Ecole Doctorale des Sciences et Technologie EDST, PRASE, Université Libanaise, Hadath, Lebanon

Received 15 August 2015; Accepted 8 October 2015

Academic Editor: Yuebing Zheng

Copyright © 2015 Fatima Abi-Ghaida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Chandra, T. Ahmad, R. F. Barth, and G. W. Kabalka, “Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS),” Journal of Microscopy, vol. 254, no. 3, pp. 146–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Raymond, “Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT),” Applied Radiation and Isotopes, vol. 88, pp. 2–11, 2014. View at Publisher · View at Google Scholar
  3. N. S. Hosmane, Ed., Boron Science: New Technologies and Applications, CRC Press, 2012.
  4. Y. Zhu, K. C. Yan, J. A. Maguire, and N. S. Hosmane, “Boron-based hybrid nanostructures: novel applications of modern materials,” in Hybrid Nanomaterials: Synthesis, Characterization and Applications, B. P. S. Chauhan, Ed., pp. 181–198, John Wiley & Sons, Hoboken, NJ, USA, 2011. View at Google Scholar
  5. Z. Yinghuai, K. C. Yan, J. A. Maguire, and N. S. Hosmane, “Recent developments in boron neutron capture therapy (BNCT) driven by nanotechnology,” Current Chemical Biology, vol. 1, no. 2, pp. 141–149, 2007. View at Publisher · View at Google Scholar
  6. A. H. Soloway, W. Tjarks, B. A. Barnum et al., “The chemistry of neutron capture therapy,” Chemical Reviews, vol. 98, no. 4, pp. 1515–1562, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Tachikawa, T. Miyoshi, H. Koganei et al., “Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy,” Chemical Communications, vol. 50, no. 82, pp. 12325–12328, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Feakes, K. Shelly, C. B. Knobler, and M. F. Hawthorne, “Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 8, pp. 3029–3033, 1994. View at Publisher · View at Google Scholar
  9. M. V. Backer, T. I. Gaynutdinov, V. Patel et al., “Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature,” Molecular Cancer Therapeutics, vol. 4, no. 9, pp. 1423–1429, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. H. Zhu, T. P. Ang, K. Carpenter, J. A. Maguire, N. S. Hosmane, and M. Takagaki, “Substituted carborane-appended water-soluble single-wall carbon nanotubes:  new approach to boron neutron capture therapy drug delivery,” Journal of the American Chemical Society, vol. 127, no. 27, pp. 9875–9880, 2005. View at Publisher · View at Google Scholar
  11. T. T. Xu, J.-G. Zheng, N. Wu et al., “Crystalline boron nanoribbons: synthesis and characterization,” Nano Letters, vol. 4, no. 5, pp. 963–968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Ciuparu, R. F. Klie, Y. Zhu, and L. Pfefferle, “Synthesis of pure boron single-wall nanotubes,” The Journal of Physical Chemistry B, vol. 108, no. 13, pp. 3967–3969, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Zhu, Y. Lin, Y. Z. Zhu, J. Lu, J. A. Maguire, and N. S. Hosmane, “Boron drug delivery via encapsulated magnetic nanocomposites: a new approach for BNCT in cancer treatment,” Journal of Nanomaterials, vol. 2010, Article ID 409320, 8 pages, 2010. View at Publisher · View at Google Scholar
  14. C. Alexiou, W. Arnold, R. J. Klein et al., “Locoregional cancer treatment with magnetic drug targeting,” Cancer Research, vol. 60, no. 23, pp. 6641–6648, 2000. View at Google Scholar · View at Scopus
  15. M. Scholz and E. Hey-Hawkins, “Carbaboranes as pharmacophores: properties, synthesis, and application strategies,” Chemical Reviews, vol. 111, no. 11, pp. 7035–7062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Viñas and C. Teixidor, “The uniqueness of boron as a novel challenging element for drugs in pharmacology, medicine and for smart biomaterials,” Future Medicinal Chemistry, vol. 5, no. 6, pp. 617–619, 2013. View at Publisher · View at Google Scholar
  17. J. F. Valliant, K. J. Guenther, A. S. King et al., “The medicinal chemistry of carboranes,” Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 173–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Alberti, A. Toppino, S. Geninatti Crich et al., “Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications,” Organic and Biomolecular Chemistry, vol. 12, no. 15, pp. 2457–2467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Chen, J. Yang, G. Lu et al., “One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging,” Molecular Pharmaceutics, vol. 11, no. 10, pp. 3291–3299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-H. Lai, N.-C. Lai, Y.-J. Chuang, F.-I. Chou, C.-M. Yang, and C.-C. Lin, “Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy,” Nanoscale, vol. 5, no. 19, pp. 9412–9418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Toppino, M. E. Bova, S. G. Crich et al., “A carboranederivative ‘click’ reaction under heterogeneous conditions for the synthesis of a promising lipophilic MRI/GdBNCT agent,” Chemistry, vol. 19, no. 2, pp. 721–728, 2013. View at Publisher · View at Google Scholar
  22. L. N. Goswami, L. Ma, S. Chakravarty, Q. Cai, S. S. Jalisatgi, and M. F. Hawthorne, “Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agent,” Inorganic Chemistry, vol. 52, no. 4, pp. 1694–1700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Akimov, E. Y. Matveev, A. S. Kubasov, G. A. Razgonyaeva, K. Y. Zhizhin, and N. T. Kuznetsov, “Polydentate ligands based on closo-decaborate anion for the synthesis of gadolinium(III) complexes,” Russian Chemical Bulletin, vol. 62, no. 6, pp. 1417–1421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Croissant, A. Chaix, O. Mongin et al., “Two-photon-triggered drug delivery via fluorescent nanovalves,” Small, vol. 10, no. 9, pp. 1752–1755, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. N. T. Chen, S. H. Cheng, J. S. Souris, C. T. Chen, C. Y. Moub, and L. W. Lo, “Theranostic applications of mesoporous silica nanoparticles and their organic/inorganic hybrids,” Journal of Materials Chemistry B, vol. 1, no. 25, pp. 3128–3135, 2013. View at Publisher · View at Google Scholar
  26. Z. Li, J. C. Barnes, A. Bosoy, J. F. Stoddart, and J. I. Zink, “Mesoporous silica nanoparticles in biomedical applications,” Chemical Society Reviews, vol. 41, no. 7, pp. 2590–2605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. W. Ambrogio, C. R. Thomas, Y.-L. Zhao, J. I. Zink, and J. F. Stoddart, “Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine,” Accounts of Chemical Research, vol. 44, no. 10, pp. 903–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. K. E. Sapsford, W. R. Algar, L. Berti et al., “Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology,” Chemical Reviews, vol. 113, no. 3, pp. 1904–2074, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Mahon, D. R. Hristov, and K. A. Dawson, “Stabilising fluorescent silica nanoparticles against dissolution effects for biological studies,” Chemical Communications, vol. 48, no. 64, pp. 7970–7972, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. J. Soenen, B. Manshian, S. H. Doak, S. C. De Smedt, and K. Braeckmans, “Fluorescent non-porous silica nanoparticles for long-term cell monitoring: cytotoxicity and particle functionality,” Acta Biomaterialia, vol. 9, no. 11, pp. 9183–9193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Helle, E. Rampazzo, M. Monchanin et al., “Surface chemistry architecture of silica nanoparticles determine the efficiency of in Vivo fluorescence lymph node mapping,” ACS Nano, vol. 7, no. 10, pp. 8645–8657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Iltis, J. Choi, M. Vollmers, M. Shenoi, J. Bischof, and G. J. Metzger, “In vivo detection of the effects of preconditioning on LNCaP tumors by a TNF-α nanoparticle construct using MRI,” NMR in Biomedicine, vol. 27, no. 9, pp. 1063–1069, 2014. View at Publisher · View at Google Scholar
  33. J. O'Shaughnessy, W. J. Gradishar, P. Bhar, and J. Iglesias, “Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis,” Breast Cancer Research and Treatment, vol. 138, no. 3, pp. 829–837, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Choi, A. A. Burns, R. M. Williams et al., “Core-shell silica nanoparticles as fluorescent labels for nanomedicine,” Journal of Biomedical Optics, vol. 12, no. 6, Article ID 064007, 11 pages, 2007. View at Publisher · View at Google Scholar
  35. F. Abi-Ghaida, Z. Laila, G. Ibrahim, D. Naoufal, and A. Mehdi, “New triethoxysilylated 10-vertex closo-decaborate clusters. Synthesis and controlled immobilization into mesoporous silica,” Dalton Transactions, vol. 43, no. 34, pp. 13087–13095, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. International Standard, “Particle size analysis—dynamic light scattering,” ISO 22412, International Organization for Standardization (ISO), 2008. View at Google Scholar
  37. B.-S. Bae and S.-Y. Kwak, US Patent Application Publication 20120153229 A1 20120621, 2012.
  38. W. Stöber, A. Fink, and E. Bohn, “Controlled growth of monodisperse silica spheres in the micron size range,” Journal of Colloid And Interface Science, vol. 26, no. 1, pp. 62–69, 1968. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Schulz and C. McDonagh, “Intracellular sensing and cell diagnostics using fluorescent silica nanoparticles,” Soft Matter, vol. 8, no. 9, pp. 2579–2585, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Burns, H. Ow, and U. Wiesner, “Fluorescent core-shell silica nanoparticles: towards ‘Lab on a Particle’ architectures for nanobiotechnology,” Chemical Society Reviews, vol. 35, no. 11, pp. 1028–1042, 2006. View at Publisher · View at Google Scholar
  41. H. Ow, D. R. Larson, M. Srivastava, B. A. Baird, W. W. Webb, and U. Wiesnert, “Bright and stable core-shell fluorescent silica nanoparticles,” Nano Letters, vol. 5, no. 1, pp. 113–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Imhof, M. Megens, J. J. Engelberts, D. T. N. De Lang, R. Sprik, and W. L. Vos, “Spectroscopy of fluorescein (FITC) dyed colloidal silica spheres,” The Journal of Physical Chemistry B, vol. 103, no. 9, pp. 1408–1415, 1999. View at Publisher · View at Google Scholar · View at Scopus